Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 14 results.
User Information
Export Records
  1. 1.   Chemoattractant receptors as pharmacological targets for elimination of glioma stem-like cells
  2. Yao, X. H.; Liu, Y.; Chen, K. Q.; Gong, W. H.; Liu, M. Y.; Bian, X. W.; Wang, J. M.
  3. International Immunopharmacology. 2011, Dec; 11(12): 1961-1966.
  1. 2.   Transduction of the gene coding for a human G-protein coupled receptor FPRL1 in mouse tumor cells increases host anti-tumor immunity
  2. Hu, J. Y.; Li, G. C.; Tong, Y. Q.; Li, Y. H.; Zhou, G. H.; He, X. J.; Xie, P. L.; Wang, J. M.; Sun, Q. B.
  3. International Immunopharmacology. 2005, JUN; 5(6): 971-980.
  1. 3.   Autoantigens signal through chemokine receptors: uveitis antigens induce CXCR3- and CXCR5-expressing lymphocytes and immature dendritic cells to migrate
  2. Howard, O. M. Z.; Dong, H. F.; Su, S. B.; Caspi, R. R.; Chen, X.; Plotz, P.; Oppenheim, J. J.
  3. Blood. 2005, JUN 1; 105(11): 4207-4214.
  1. 4.   Chemotaxis and calcium responses of phagocytes to formyl peptide receptor ligands is differentially regulated by cyclic ADP ribose
  2. Partida-Sanchez, S.; Iribarren, P.; Moreno-Garcia, M. E.; Gao, X. L.; Murphy, P. M.; Oppenheimer, N.; Wang, J. M.; Lund, F. E.
  3. Journal of Immunology. 2004 172(3): 1896-1906.
  1. 5.   Identification of neutrophil granule protein cathepsin G as a novel chemotactic agonist for the G protein-coupled formyl peptide receptor
  2. Sun, R. H.; Iribarren, P.; Zhang, N.; Zhou, Y.; Gong, W. H.; Cho, E. H.; Lockett, S.; Chertov, O.; Bednar, F.; Rogers, T. J.; Oppenheim, J. J.; Wang, J. M.
  3. Journal of Immunology. 2004 173(1): 428-436.
  1. 6.   Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation
  2. Yang, D.; Chen, Q.; Gertz, B.; He, R.; Phulsuksombati, M.; Ye, R. D.; Oppenheim, J. J.
  3. Journal of Leukocyte Biology. 2002 72(3): 598-607.
  1. 7.   Receptors for chemotactic formyl peptides as pharmacological targets
  2. Le, Y. Y.; Yang, Y. M.; Cui, Y. H.; Yazawa, H.; Gong, W. H.; Qiu, C. P.; Wang, J. M.
  3. International Immunopharmacology. 2002 2(1): 1-13.
  1. 8.   Pleiotropic roles of formyl peptide receptors
  2. Le, Y. Y.; Oppenheim, J. J.; Wang, J. M.
  3. Cytokine & Growth Factor Reviews. 2001 12(1): 91-105.
  1. 9.   Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation
  2. Le, Y. Y.; Gong, W. H.; Li, B. Q.; Dunlop, N. M.; Shen, W. P.; Su, S. B.; Ye, R. D.; Wang, J. M.
  3. Journal of Immunology. 1999 163(12): 6777-6784.
  1. 10.   T21/DP107, a synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors
  2. Su, S. B.; Gao, J. L.; Gong, W. H.; Dunlop, N. M.; Murphy, P. M.; Oppenheim, J. J.; Wang, J. M.
  3. Journal of Immunology. 1999 162(10): 5924-5930.
  1. 11.   A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells
  2. Su, S. B.; Gong, W. H.; Gao, J. L.; Shen, W. P.; Murphy, P. M.; Oppenheim, J. J.; Wang, J. M.
  3. Journal of Experimental Medicine. 1999 189(2): 395-402.
  1. 13.   T20/DP178, an ectodomain peptide of human immunodeficiency virus type 1 gp41, is an activator of human phagocyte N-formyl peptide receptor
  2. Su, S. B.; Gong, W. H.; Gao, J. L.; Shen, W. P.; Grimm, M. C.; Deng, X. Y.; Murphy, P. M.; Oppenheim, J. J.; Wang, J. M.
  3. Blood. 1999 93(11): 3885-3892.
  1. 14.   Opiates Transdeactivate Chemokine Receptors - Delta and Mu Opiate Receptor-Mediated Heterologous Desensitization
  2. Grimm, M. C.; Benbaruch, A.; Taub, D. D.; Howard, O. M. Z.; Resau, J. H.; Wang, J. M.; Ali, H.; Richardson, R.; Snyderman, R.; Oppenheim, J. J.
  3. Journal of Experimental Medicine. 1998 188(2): 317-325.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel